What is the recommended starting dose of Lantus (insulin glargine) for a patient switching from Novolog 70/30 (insulin aspart protamine/insulin aspart) 15 units, 1-2 times a day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting from Novolog 70/30 to Lantus: Dosing Strategy

For a patient taking Novolog 70/30 15 units 1-2 times daily (total daily dose 15-30 units), start Lantus at 8-12 units once daily, which represents approximately 80% of the basal component of the current premixed insulin regimen. 1, 2

Calculating the Starting Dose

The basal component of 70/30 insulin represents approximately 70% of the total daily dose 2:

  • If taking 15 units once daily: Basal component = 10.5 units → Start Lantus at 8 units once daily (80% of basal component) 1, 2
  • If taking 15 units twice daily (30 units total): Basal component = 21 units → Start Lantus at 12 units once daily (80% of basal component) 1, 2

The 20% reduction from the calculated basal component prevents hypoglycemia during the transition, particularly important given the variable dosing pattern 2.

Critical Gap: Loss of Prandial Coverage

This conversion creates a significant therapeutic gap because Novolog 70/30 provides both basal AND prandial insulin coverage, while Lantus provides only basal coverage. 2 The 30% rapid-acting component (4.5-9 units daily) will be lost in this transition.

Addressing the Prandial Gap

You have three options:

  • Add rapid-acting insulin before meals: Start with 4 units of rapid-acting insulin (lispro, aspart, or glulisine) before the largest meal, or use 10% of the basal dose 1, 2
  • Intermediate step: Add rapid-acting insulin before only the largest meal initially, then expand to other meals if needed 2
  • Monitor closely: If the patient's A1C is near target and postprandial glucose remains acceptable, you may defer adding prandial insulin 2

Titration Protocol

Increase Lantus by 2 units every 3 days if fasting glucose is 140-179 mg/dL, or by 4 units every 3 days if fasting glucose is ≥180 mg/dL, targeting fasting glucose of 80-130 mg/dL. 1, 3

If hypoglycemia occurs without clear cause, reduce the dose by 10-20% immediately 1, 3

Critical Threshold Warning

When Lantus exceeds 0.5 units/kg/day (approximately 35-40 units for an average adult), stop escalating basal insulin and add prandial insulin instead. 1 Continuing to increase basal insulin beyond this threshold leads to "overbasalization" with increased hypoglycemia risk and suboptimal control 1.

Clinical signals of overbasalization include:

  • Basal dose >0.5 units/kg/day
  • Bedtime-to-morning glucose differential ≥50 mg/dL
  • Hypoglycemia episodes
  • High glucose variability 1

Monitoring Requirements

  • Daily fasting blood glucose monitoring during titration 1, 3
  • Pre-meal and 2-hour postprandial glucose if prandial insulin is added 1
  • Reassess every 3 days during active titration 1
  • Check HbA1c every 3 months to assess overall glycemic control 1

Common Pitfalls to Avoid

  • Never use 1:1 unit conversion from total 70/30 dose to Lantus—this causes severe hypoglycemia 2
  • Don't rely on sliding scale insulin alone as prandial replacement—this reactive approach leads to poor glycemic control 2
  • Don't forget to continue metformin (unless contraindicated) when initiating basal insulin 1, 3
  • Don't delay adding prandial insulin if postprandial glucose remains elevated or HbA1c stays above target after 3-6 months 1

Patient Education Essentials

Provide comprehensive education on:

  • Self-monitoring of blood glucose, particularly fasting and pre-meal values 2
  • Recognition and treatment of hypoglycemia with 15 grams of fast-acting carbohydrate 1, 2
  • Proper injection technique and site rotation 1
  • Dietary considerations now that prandial coverage has changed 2

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Transitioning from 70/30 BID to Toujeo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initiating Insulin Glargine Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.